 Dylan Taatjes
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 35 | 2025 | 350 | 10.590 |
Why?
| | Mediator Complex | 27 | 2025 | 61 | 8.790 |
Why?
| | Transcription, Genetic | 42 | 2025 | 1454 | 7.090 |
Why?
| | Cyclin-Dependent Kinases | 15 | 2025 | 122 | 6.500 |
Why?
| | Transcription Factors | 30 | 2025 | 1734 | 3.690 |
Why?
| | Cyclin-Dependent Kinase 8 | 13 | 2025 | 50 | 3.210 |
Why?
| | Transcription Factor TFIIH | 9 | 2025 | 40 | 3.080 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2022 | 534 | 2.530 |
Why?
| | Gene Expression Regulation | 22 | 2025 | 2597 | 2.270 |
Why?
| | Promoter Regions, Genetic | 14 | 2025 | 1246 | 2.250 |
Why?
| | Transcription Initiation, Genetic | 6 | 2025 | 19 | 1.950 |
Why?
| | Transcription Factor TFIID | 3 | 2021 | 21 | 1.310 |
Why?
| | Transcriptional Activation | 8 | 2025 | 372 | 1.140 |
Why?
| | Multiprotein Complexes | 5 | 2017 | 172 | 1.110 |
Why?
| | Chromatin | 12 | 2022 | 553 | 1.060 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 317 | 0.910 |
Why?
| | Transcription Initiation Site | 4 | 2021 | 43 | 0.890 |
Why?
| | Protein Binding | 19 | 2024 | 2238 | 0.840 |
Why?
| | Transcription Factors, TFII | 4 | 2015 | 44 | 0.800 |
Why?
| | Antibiotics, Antineoplastic | 7 | 2001 | 140 | 0.800 |
Why?
| | Interferons | 1 | 2025 | 186 | 0.790 |
Why?
| | Cryoelectron Microscopy | 8 | 2025 | 221 | 0.740 |
Why?
| | Cell Nucleus | 7 | 2021 | 588 | 0.710 |
Why?
| | Protein Subunits | 8 | 2015 | 229 | 0.700 |
Why?
| | Saccharomyces cerevisiae | 6 | 2022 | 573 | 0.680 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2022 | 414 | 0.670 |
Why?
| | Trans-Activators | 6 | 2011 | 396 | 0.670 |
Why?
| | Doxorubicin | 8 | 2000 | 401 | 0.650 |
Why?
| | Humans | 73 | 2025 | 145475 | 0.630 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 981 | 0.620 |
Why?
| | Cell Proliferation | 2 | 2025 | 2507 | 0.590 |
Why?
| | Daunorubicin | 7 | 2000 | 25 | 0.590 |
Why?
| | Phosphorylation | 10 | 2025 | 1707 | 0.580 |
Why?
| | Drosophila | 1 | 2020 | 164 | 0.560 |
Why?
| | Phosphoproteins | 2 | 2023 | 337 | 0.560 |
Why?
| | Signal Transduction | 8 | 2025 | 5216 | 0.560 |
Why?
| | Phenanthrenes | 1 | 2018 | 12 | 0.550 |
Why?
| | Diterpenes | 1 | 2018 | 26 | 0.550 |
Why?
| | Drosophila Proteins | 1 | 2020 | 213 | 0.540 |
Why?
| | Molecular Biology | 1 | 2018 | 58 | 0.540 |
Why?
| | Down Syndrome | 1 | 2025 | 525 | 0.540 |
Why?
| | Biophysics | 1 | 2018 | 75 | 0.530 |
Why?
| | Cell Line | 9 | 2025 | 2823 | 0.520 |
Why?
| | Formaldehyde | 6 | 2000 | 65 | 0.510 |
Why?
| | Polycyclic Compounds | 2 | 2016 | 13 | 0.500 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 18 | 0.500 |
Why?
| | Osteosarcoma | 1 | 2017 | 82 | 0.490 |
Why?
| | Models, Biological | 3 | 2020 | 1764 | 0.480 |
Why?
| | Animals | 29 | 2025 | 38030 | 0.470 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2015 | 9 | 0.460 |
Why?
| | Porins | 1 | 2015 | 18 | 0.460 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2015 | 5 | 0.450 |
Why?
| | Mediator Complex Subunit 1 | 3 | 2020 | 6 | 0.440 |
Why?
| | E1A-Associated p300 Protein | 1 | 2015 | 13 | 0.440 |
Why?
| | HeLa Cells | 11 | 2019 | 632 | 0.440 |
Why?
| | RNA | 1 | 2021 | 910 | 0.440 |
Why?
| | Bone Neoplasms | 1 | 2017 | 259 | 0.430 |
Why?
| | Leiomyoma | 1 | 2015 | 61 | 0.420 |
Why?
| | Protein Kinases | 1 | 2016 | 312 | 0.410 |
Why?
| | Uterine Neoplasms | 1 | 2015 | 98 | 0.410 |
Why?
| | DNA | 7 | 2022 | 1435 | 0.400 |
Why?
| | Estrogen Receptor alpha | 1 | 2015 | 151 | 0.400 |
Why?
| | Protein Conformation | 7 | 2021 | 938 | 0.390 |
Why?
| | Protein Structure, Quaternary | 4 | 2021 | 116 | 0.390 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 454 | 0.380 |
Why?
| | Epirubicin | 4 | 2002 | 4 | 0.370 |
Why?
| | DNA Helicases | 4 | 2022 | 136 | 0.360 |
Why?
| | Antineoplastic Agents | 7 | 2020 | 2214 | 0.350 |
Why?
| | HCT116 Cells | 4 | 2021 | 76 | 0.350 |
Why?
| | Enzyme Activation | 3 | 2020 | 762 | 0.350 |
Why?
| | Genes, p53 | 3 | 2021 | 67 | 0.340 |
Why?
| | Enhancer Elements, Genetic | 5 | 2024 | 191 | 0.340 |
Why?
| | Imidazoles | 3 | 2021 | 247 | 0.310 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 67 | 0.310 |
Why?
| | Histones | 3 | 2015 | 666 | 0.300 |
Why?
| | DNA Repair | 4 | 2022 | 254 | 0.300 |
Why?
| | Mass Spectrometry | 9 | 2015 | 730 | 0.300 |
Why?
| | Tumor Cells, Cultured | 8 | 2017 | 886 | 0.290 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 1480 | 0.290 |
Why?
| | Proteomics | 1 | 2016 | 1188 | 0.290 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.290 |
Why?
| | Cell Cycle | 2 | 2025 | 598 | 0.280 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1443 | 0.280 |
Why?
| | Piperazines | 3 | 2021 | 375 | 0.280 |
Why?
| | Models, Molecular | 8 | 2015 | 1598 | 0.280 |
Why?
| | DNA Adducts | 5 | 1999 | 16 | 0.270 |
Why?
| | Serine | 3 | 2023 | 143 | 0.270 |
Why?
| | Histone Acetyltransferases | 1 | 2008 | 57 | 0.260 |
Why?
| | Nuclear Proteins | 4 | 2020 | 740 | 0.250 |
Why?
| | Recombinant Proteins | 6 | 2020 | 1368 | 0.250 |
Why?
| | Repressor Proteins | 2 | 2014 | 429 | 0.250 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 42 | 0.240 |
Why?
| | Mitochondria | 1 | 2013 | 992 | 0.240 |
Why?
| | Protein Isoforms | 2 | 2021 | 397 | 0.240 |
Why?
| | Crystallography, X-Ray | 4 | 2017 | 486 | 0.220 |
Why?
| | Substrate Specificity | 3 | 2023 | 387 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 425 | 0.220 |
Why?
| | Proteome | 2 | 2023 | 514 | 0.220 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 201 | 0.220 |
Why?
| | Genes, Regulator | 1 | 2004 | 35 | 0.210 |
Why?
| | Protein Structure, Tertiary | 6 | 2013 | 855 | 0.210 |
Why?
| | Receptors, Calcitriol | 1 | 2004 | 55 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2019 | 784 | 0.190 |
Why?
| | Threonine | 1 | 2023 | 44 | 0.190 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2020 | 881 | 0.190 |
Why?
| | Aging | 1 | 2013 | 1969 | 0.180 |
Why?
| | Yeasts | 1 | 2022 | 51 | 0.180 |
Why?
| | Escherichia coli | 2 | 2017 | 835 | 0.180 |
Why?
| | Molecular Probes | 1 | 2022 | 33 | 0.180 |
Why?
| | DNA, Neoplasm | 2 | 1999 | 158 | 0.180 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 3 | 2010 | 6 | 0.180 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 321 | 0.180 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2010 | 56 | 0.180 |
Why?
| | Nucleic Acid Conformation | 5 | 2016 | 723 | 0.170 |
Why?
| | HL-60 Cells | 1 | 2020 | 30 | 0.160 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.160 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 293 | 0.160 |
Why?
| | Fluorouracil | 1 | 2021 | 231 | 0.160 |
Why?
| | Cell Survival | 2 | 2020 | 1100 | 0.160 |
Why?
| | Software | 1 | 2025 | 680 | 0.150 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 333 | 0.150 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 51 | 0.140 |
Why?
| | Genome, Human | 1 | 2021 | 420 | 0.140 |
Why?
| | Genetic Variation | 1 | 2004 | 972 | 0.140 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2018 | 19 | 0.140 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2018 | 36 | 0.140 |
Why?
| | Alkylating Agents | 1 | 1998 | 24 | 0.140 |
Why?
| | Alternative Splicing | 1 | 2020 | 247 | 0.140 |
Why?
| | Epoxy Compounds | 1 | 2018 | 31 | 0.140 |
Why?
| | Anthracyclines | 1 | 1998 | 49 | 0.140 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2025 | 62 | 0.130 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 21 | 0.130 |
Why?
| | RNA Splicing | 1 | 2019 | 284 | 0.130 |
Why?
| | STAT1 Transcription Factor | 2 | 2019 | 66 | 0.130 |
Why?
| | Fibroblasts | 3 | 2019 | 1025 | 0.130 |
Why?
| | Bacterial Proteins | 1 | 2004 | 967 | 0.130 |
Why?
| | Mutation | 3 | 2021 | 4075 | 0.130 |
Why?
| | Biology | 1 | 2018 | 88 | 0.130 |
Why?
| | Drug Design | 1 | 1998 | 175 | 0.130 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2017 | 48 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2020 | 630 | 0.120 |
Why?
| | Research | 1 | 2020 | 430 | 0.120 |
Why?
| | HEK293 Cells | 5 | 2019 | 741 | 0.120 |
Why?
| | Mitosis | 1 | 2017 | 193 | 0.120 |
Why?
| | DNA Damage | 1 | 2019 | 437 | 0.120 |
Why?
| | Peptides | 1 | 2022 | 998 | 0.120 |
Why?
| | RNA, Bacterial | 1 | 2017 | 182 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 431 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 401 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 928 | 0.120 |
Why?
| | Genes, Neoplasm | 1 | 2015 | 26 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2017 | 320 | 0.110 |
Why?
| | Glutathione | 2 | 2013 | 370 | 0.110 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2020 | 130 | 0.110 |
Why?
| | Cholesterol | 1 | 2017 | 408 | 0.110 |
Why?
| | Alkylation | 4 | 1999 | 27 | 0.110 |
Why?
| | Neoplasms | 2 | 2020 | 2906 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1038 | 0.110 |
Why?
| | Quinine | 1 | 2014 | 20 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 820 | 0.110 |
Why?
| | Antimalarials | 1 | 2014 | 35 | 0.110 |
Why?
| | Models, Genetic | 2 | 2011 | 524 | 0.110 |
Why?
| | Antigen-Antibody Complex | 1 | 2014 | 69 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2014 | 75 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 337 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2015 | 145 | 0.100 |
Why?
| | RNA, Untranslated | 1 | 2015 | 121 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 74 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2013 | 58 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 37 | 0.100 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 15 | 0.100 |
Why?
| | RNA-Binding Protein FUS | 1 | 2012 | 13 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2013 | 2883 | 0.090 |
Why?
| | Macromolecular Substances | 2 | 2004 | 216 | 0.090 |
Why?
| | Epigenomics | 1 | 2013 | 114 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 1997 | 592 | 0.090 |
Why?
| | Cell Line, Tumor | 5 | 2024 | 3542 | 0.090 |
Why?
| | Pyrococcus furiosus | 1 | 2010 | 3 | 0.080 |
Why?
| | Transcription Factor TFIIB | 1 | 2010 | 13 | 0.080 |
Why?
| | Protein Multimerization | 1 | 2012 | 204 | 0.080 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 172 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2013 | 452 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2129 | 0.080 |
Why?
| | Archaeal Proteins | 1 | 2010 | 50 | 0.080 |
Why?
| | DNA, Single-Stranded | 1 | 2011 | 117 | 0.080 |
Why?
| | Biochemistry | 1 | 2010 | 36 | 0.080 |
Why?
| | Serum Response Factor | 1 | 2010 | 33 | 0.080 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 265 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2011 | 119 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2010 | 124 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 1998 | 1067 | 0.080 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2010 | 108 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 376 | 0.070 |
Why?
| | DNA Polymerase II | 1 | 2009 | 35 | 0.070 |
Why?
| | Coenzymes | 1 | 2008 | 19 | 0.070 |
Why?
| | Pol1 Transcription Initiation Complex Proteins | 1 | 2008 | 5 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1476 | 0.070 |
Why?
| | Cell Lineage | 2 | 2024 | 377 | 0.070 |
Why?
| | Cyclins | 1 | 2008 | 79 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 686 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2016 | 2803 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1048 | 0.070 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 450 | 0.070 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 139 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3413 | 0.070 |
Why?
| | Telomere | 1 | 2011 | 287 | 0.070 |
Why?
| | Dithiothreitol | 2 | 1997 | 19 | 0.060 |
Why?
| | Acetylation | 1 | 2008 | 259 | 0.060 |
Why?
| | Protein Domains | 2 | 2019 | 311 | 0.060 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 471 | 0.060 |
Why?
| | Vesiculovirus | 2 | 2019 | 17 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3342 | 0.060 |
Why?
| | Mice | 7 | 2019 | 18329 | 0.060 |
Why?
| | Microscopy, Electron | 3 | 2002 | 414 | 0.060 |
Why?
| | Hydrogen Peroxide | 2 | 1997 | 335 | 0.060 |
Why?
| | Cell Division | 2 | 2015 | 756 | 0.060 |
Why?
| | Molecular Structure | 2 | 2014 | 486 | 0.050 |
Why?
| | STAT3 Transcription Factor | 2 | 2019 | 206 | 0.050 |
Why?
| | Vitamin D Response Element | 1 | 2004 | 1 | 0.050 |
Why?
| | Sp1 Transcription Factor | 1 | 2004 | 24 | 0.050 |
Why?
| | Hydrolysis | 3 | 2002 | 197 | 0.050 |
Why?
| | Kinetics | 2 | 2016 | 1567 | 0.050 |
Why?
| | Binding Sites | 2 | 2004 | 1310 | 0.050 |
Why?
| | Phosphothreonine | 1 | 2023 | 6 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1767 | 0.050 |
Why?
| | Phosphoserine | 1 | 2023 | 25 | 0.050 |
Why?
| | Species Specificity | 1 | 2004 | 546 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2023 | 118 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2002 | 666 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2002 | 90 | 0.040 |
Why?
| | Cross-Linking Reagents | 3 | 2015 | 206 | 0.040 |
Why?
| | TATA-Box Binding Protein | 2 | 2013 | 20 | 0.040 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2002 | 62 | 0.040 |
Why?
| | Mutagenesis | 1 | 2022 | 194 | 0.040 |
Why?
| | Base Sequence | 2 | 2016 | 2170 | 0.040 |
Why?
| | Genetic Techniques | 1 | 2021 | 66 | 0.040 |
Why?
| | Oligonucleotides | 2 | 1999 | 153 | 0.040 |
Why?
| | Breast | 1 | 2021 | 156 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2004 | 492 | 0.040 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2020 | 27 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 159 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2019 | 5 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2021 | 129 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2019 | 42 | 0.040 |
Why?
| | STAT Transcription Factors | 1 | 2019 | 25 | 0.040 |
Why?
| | Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 14 | 0.040 |
Why?
| | Immunoglobulin G | 2 | 2014 | 892 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 1999 | 83 | 0.040 |
Why?
| | Models, Chemical | 2 | 1997 | 250 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 66 | 0.040 |
Why?
| | Dexamethasone | 1 | 2021 | 365 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2019 | 86 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 165 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 407 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 500 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 1998 | 112 | 0.030 |
Why?
| | Drug Carriers | 1 | 1999 | 136 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 583 | 0.030 |
Why?
| | Microscopy, Atomic Force | 2 | 2014 | 128 | 0.030 |
Why?
| | Synaptic Vesicles | 1 | 1998 | 40 | 0.030 |
Why?
| | Buffers | 1 | 1997 | 56 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1998 | 194 | 0.030 |
Why?
| | Anaerobiosis | 1 | 1997 | 65 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 192 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1997 | 106 | 0.030 |
Why?
| | Oxazoles | 1 | 1997 | 48 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 211 | 0.030 |
Why?
| | Nucleic Acids | 1 | 1998 | 70 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 779 | 0.030 |
Why?
| | Xanthine Oxidase | 1 | 1997 | 79 | 0.030 |
Why?
| | beta Catenin | 1 | 2019 | 254 | 0.030 |
Why?
| | NAD | 1 | 1997 | 79 | 0.030 |
Why?
| | Uridine Triphosphate | 1 | 2016 | 9 | 0.030 |
Why?
| | Breast Neoplasms | 2 | 2000 | 2382 | 0.030 |
Why?
| | Sulfhydryl Reagents | 1 | 1996 | 12 | 0.030 |
Why?
| | Computer Simulation | 1 | 2021 | 1003 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1996 | 81 | 0.030 |
Why?
| | Nerve Tissue Proteins | 2 | 1998 | 591 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1998 | 531 | 0.030 |
Why?
| | Fluorescence | 1 | 2017 | 159 | 0.030 |
Why?
| | Guanosine Triphosphate | 1 | 2016 | 89 | 0.030 |
Why?
| | Immunologic Techniques | 2 | 2014 | 38 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 361 | 0.030 |
Why?
| | Oxidants | 1 | 1996 | 99 | 0.030 |
Why?
| | Computational Biology | 1 | 2021 | 669 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2016 | 362 | 0.030 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2015 | 9 | 0.030 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2015 | 23 | 0.030 |
Why?
| | Chromaffin Granules | 1 | 1995 | 3 | 0.030 |
Why?
| | Adrenal Medulla | 1 | 1995 | 10 | 0.030 |
Why?
| | Genes, Tumor Suppressor | 1 | 2015 | 85 | 0.030 |
Why?
| | Female | 5 | 2021 | 78845 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 627 | 0.030 |
Why?
| | Cytoplasmic Granules | 1 | 1995 | 60 | 0.030 |
Why?
| | Flow Cytometry | 1 | 1999 | 1162 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 396 | 0.030 |
Why?
| | Iron | 1 | 1997 | 357 | 0.030 |
Why?
| | beta 2-Glycoprotein I | 1 | 2014 | 5 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2021 | 1131 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2014 | 21 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 14 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 1995 | 93 | 0.030 |
Why?
| | Tripartite Motif-Containing Protein 28 | 1 | 2014 | 15 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1995 | 153 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 69 | 0.030 |
Why?
| | Antibodies, Antiphospholipid | 1 | 2014 | 29 | 0.030 |
Why?
| | Hydroxychloroquine | 1 | 2014 | 65 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2013 | 13 | 0.020 |
Why?
| | Down-Regulation | 1 | 2015 | 618 | 0.020 |
Why?
| | Muscle Hypotonia | 1 | 2013 | 33 | 0.020 |
Why?
| | Anus, Imperforate | 1 | 2013 | 24 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2013 | 73 | 0.020 |
Why?
| | Phospholipids | 1 | 2014 | 214 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2013 | 50 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2013 | 141 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 847 | 0.020 |
Why?
| | Ubiquitination | 1 | 2013 | 118 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2013 | 277 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3124 | 0.020 |
Why?
| | Proteolysis | 1 | 2013 | 172 | 0.020 |
Why?
| | Constipation | 1 | 2013 | 98 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1998 | 1164 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2011 | 88 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 749 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2010 | 18 | 0.020 |
Why?
| | Serum Response Element | 1 | 2010 | 6 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 309 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2010 | 79 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 371 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 105 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 447 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1179 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 776 | 0.020 |
Why?
| | Neurons | 1 | 1998 | 1649 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5983 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2864 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4148 | 0.020 |
Why?
| | Sialic Acids | 1 | 1985 | 8 | 0.010 |
Why?
| | Sialyltransferases | 1 | 1985 | 13 | 0.010 |
Why?
| | Transferases | 1 | 1985 | 27 | 0.010 |
Why?
| | Golgi Apparatus | 1 | 1985 | 99 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2002 | 92 | 0.010 |
Why?
| | Immunoblotting | 1 | 2002 | 295 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 331 | 0.010 |
Why?
| | Rats | 3 | 1998 | 5584 | 0.010 |
Why?
| | Ligands | 1 | 2002 | 665 | 0.010 |
Why?
| | Cell Death | 1 | 2002 | 382 | 0.010 |
Why?
| | Intercalating Agents | 1 | 1999 | 4 | 0.010 |
Why?
| | Male | 2 | 2015 | 72843 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
| | R-SNARE Proteins | 1 | 1998 | 19 | 0.010 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 1998 | 25 | 0.010 |
Why?
| | Qa-SNARE Proteins | 1 | 1998 | 18 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 189 | 0.010 |
Why?
| | Catalysis | 1 | 1997 | 305 | 0.010 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 1995 | 4 | 0.010 |
Why?
| | Hemagglutinins, Viral | 1 | 1995 | 8 | 0.010 |
Why?
| | PC12 Cells | 1 | 1995 | 42 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 1995 | 43 | 0.010 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1995 | 29 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1995 | 200 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1995 | 365 | 0.010 |
Why?
| | Cell Membrane | 1 | 1998 | 707 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1995 | 335 | 0.010 |
Why?
| | Transfection | 1 | 1995 | 926 | 0.010 |
Why?
| | Cattle | 1 | 1995 | 946 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1998 | 2524 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4560 | 0.010 |
Why?
| | Thiamine Pyrophosphatase | 1 | 1985 | 1 | 0.000 |
Why?
| | Nucleotidases | 1 | 1985 | 6 | 0.000 |
Why?
| | Glycoproteins | 1 | 1985 | 354 | 0.000 |
Why?
| | Liver | 1 | 1985 | 1896 | 0.000 |
Why?
|
|
Taatjes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|